Home
>
National Drug Code (NDC)
>
Clopidogrel
Clopidogrel - 55648-314-03 - (Clopidogrel)
Drug Information of Clopidogrel
| Product NDC: | 55648-314 |
| Proprietary Name: | Clopidogrel |
| Non Proprietary Name: | Clopidogrel |
| Active Ingredient(s): | 75 mg/1 & nbsp; Clopidogrel |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clopidogrel
| Product NDC: | 55648-314 |
| Labeler Name: | Wockhardt Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202266 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120522 |
Package Information of Clopidogrel
| Package NDC: | 55648-314-03 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (55648-314-03) |
NDC Information of Clopidogrel
| NDC Code | 55648-314-03 |
| Proprietary Name | Clopidogrel |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (55648-314-03) |
| Product NDC | 55648-314 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clopidogrel |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120522 |
| Marketing Category Name | ANDA |
| Labeler Name | Wockhardt Limited |
| Substance Name | CLOPIDOGREL BISULFATE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
